- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Patent holdings for IPC class C07D 401/12
Total number of patents in this class: 14806
10-year publication summary
|
890
|
862
|
875
|
880
|
910
|
848
|
803
|
913
|
847
|
522
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4867 |
329 |
| Boehringer Ingelheim International GmbH | 4640 |
243 |
| Novartis AG | 10726 |
235 |
| Janssen Pharmaceutica N.V. | 3381 |
201 |
| F. Hoffmann-La Roche AG | 7942 |
192 |
| Takeda Pharmaceutical Company Limited | 2707 |
184 |
| Merck Sharp & Dohme LLC | 3750 |
154 |
| AstraZeneca AB | 2899 |
133 |
| Amgen Inc. | 4097 |
119 |
| Gilead Sciences, Inc. | 2042 |
119 |
| Bayer Pharma AG | 1054 |
115 |
| Pfizer Inc. | 3364 |
114 |
| Centre National de La Recherche Scientifique | 10498 |
111 |
| Hoffmann-La Roche Inc. | 3456 |
106 |
| BASF SE | 20961 |
106 |
| Merck Patent GmbH | 5820 |
106 |
| Genentech, Inc. | 3988 |
92 |
| Bayer Cropscience AG | 2030 |
85 |
| Epizyme, Inc. | 374 |
83 |
| The Regents of the University of California | 20035 |
76 |
| Other owners | 11903 |